ImmunoPrecise Antibodies Ltd. (IPA) Financials
IPA Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2024-01-31 | 56.3 million | 17.5 million |
| 2023-10-31 | 54.7 million | 17.1 million |
| 2023-07-31 | 60.3 million | 10.3 million |
| 2023-04-30 | 57.0 million | 14.7 million |
IPA Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2024-01-31 | -397433 | 221044 |
| 2023-10-31 | -386287 | 214845 |
| 2023-07-31 | -7.8 million | 572706 |
| 2023-04-30 | -2.0 million | 465722 |
IPA Net Income
No data available :(
IPA Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2024-01-31 | 4.5 million | - | - |
| 2023-10-31 | 4.4 million | - | 6.9 million |
| 2023-07-31 | 14.5 million | - | 7.4 million |
| 2023-04-30 | 6.1 million | - | 5.3 million |
IPA Shares Outstanding
IPA Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2024-01-31 | 222533 | 771795 | 2.5 million | 685461 |
| 2023-10-31 | 216292 | 750150 | 2.4 million | 666237 |
| 2023-07-31 | 67155 | 4.4 million | 3.7 million | 234666 |
| 2023-04-30 | 338307 | 367598 | 4.9 million | 683937 |
IPA Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2024-01-31 | 4.6 million | 2.4 million |
| 2023-10-31 | 4.4 million | 2.3 million |
| 2023-07-31 | 3.5 million | 1.7 million |
| 2023-04-30 | 4.1 million | 1.7 million |
IPA
Price: $1.28
52 week price:
Earnings Per Share: -0.48 USD
P/E Ratio: -5.02
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 28913
Market Capitalization: 37.9 million